Ligand Substitutional Effects on Molecular Dynamics and Broadband Near-White Emission in 2D 2‑Fluoroethylammonium Cadmium Chlorobromide by Maciej Ptak (1713061)

“…In this article, structural, thermal, phonon, and optical effects of partial halide ligand replacement in two-dimensional cadmium chloride templated by 2-fluoroethylammonium cations are discussed. …”

Sensitivity of the endemic Mf prevalence, breakpoint values, and TBRs to changes in the shape parameter of the negative binomial distribution, (<i>k</i>) describing the distributio... by Manoj Gambhir (70469)

“…<p>The <i>k</i> values were varied by maintaining the linear dependence upon Mf values (see text) but increasing/decreasing the linear component by 50% so that this value was given by i) 0.0354, ii) 0.0236, and iii) 0.0118. …”

Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy by Dae Joong Ma (5687885)

“…The vascular proportions in Sattler’s and Haller’s layers did not show a significant decrease at 6 weeks (Sattler’s: 49.7% ± 17.3%, <i>P</i> = 0.052 and Haller’s: 58.3% ± 12.9%, <i>P</i> = 0.558) but decreased significantly at 6 months (Sattler’s: 48.9% ± 12.4%, <i>P</i> < 0.001 and Haller’s: 57.7% ± 15.7%, <i>P</i> = 0.027) and 12 months after HF-PDT from the baseline values (Sattler’s: 45.8% ± 10.4%, <i>P</i> < 0.001 and Haller’s: 56.8% ± 15.7%, <i>P</i> < 0.001).…”

Age-dependent changes in the thermal stability of nuclear lamin-B and CP190. by Wei-Qi Lin (2518108)

Cofactors required for Vpu activities. by Charlotte A. Stoneham (10819125)

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

“…<b>d</b> VEGF-A165 concentrations were low in serum samples post-bevacizumab administration and remained low after further addition of bevacizumab. <b>e</b> The percent change in VEGF-A121 concentration with the addition of any (2, 20, or 200 μg/mL) concentration of bevacizumab to serum samples post-bevacizumab administration was significantly less than the percent change in VEGF-A121 concentration with the addition of 2 μg/mL concentration of bevacizumab to serum samples pre-bevacizumab administration (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: Post+2 μg/mL, <i>p</i> < 0.0001 vs Pre+2 μg/mL; Post +20 μg/mL, <i>p</i> < 0.0001 vs Pre+2 μg/mL; +200 μg/mL, <i>p</i> < 0.0001 vs Pre+2 μg/mL).…”

Photomicrographs of doublecortin-positive neurons in HVC. by Jake V. Aronowitz (11361921)

Estimated niche width for 11 native fish species in <i>Arapaima gigas</i> colonized and non-colonized lakes. by Danny Rejas (583637)

BRD4 and LANA protein form LLPS. by Tomoki Inagaki (12903779)

Adaptation affects the gain and slope of neural power spectral densities. by Brian Nils Lundstrom (14659973)

“…<i>5</i>, <i>γ = 2</i>). (c) Adaptation alters the slope of PSDs, decreases the overall gain, and affects lower frequencies (e.g. 0–10 Hz) more than higher frequencies (e.g. 30–50 Hz). …”

Fig 1 - by Veronika Mitterwallner (10323238)

The involvement of ERK5 in statin-induced Nrf2 signaling in VSMCs. by Ae-Rang Hwang (4040408)

Statistical details of data presented in Fig 16. by Piotr Popik (292215)

“…<div><p>The rapid decrease of light intensity is a potent stimulus of rats’ activity. …”

Statistical details of data presented in Fig 17. by Piotr Popik (292215)

“…<div><p>The rapid decrease of light intensity is a potent stimulus of rats’ activity. …”

Simon Nilsson’s polygon features in action. by Piotr Popik (292215)

“…<div><p>The rapid decrease of light intensity is a potent stimulus of rats’ activity. …”

Activation of HilD abrogates swimming motility. by Doaa Osama Saleh (16353149)

Cellular immune components of the pre-castration and post-castration within the tumor. by Nourridine Siewe (5081834)

Table_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

“…Crystal and electron cryo-microscopy (cryo-EM) structure analyses revealed that P36-5D2 targeted to a conserved epitope on the receptor-binding domain of the spike protein, withstanding the three key mutations—K417N, E484K, and N501Y—found in the variants that are responsible for escape from many potent neutralizing mAbs, including some already approved for emergency use authorization (EUA). …”

Image_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

“…Crystal and electron cryo-microscopy (cryo-EM) structure analyses revealed that P36-5D2 targeted to a conserved epitope on the receptor-binding domain of the spike protein, withstanding the three key mutations—K417N, E484K, and N501Y—found in the variants that are responsible for escape from many potent neutralizing mAbs, including some already approved for emergency use authorization (EUA). …”

Data_Sheet_2_Relating Depth and Diversity of Bivalvia and Gastropoda in Two Contrasting Sub-Arctic Marine Regions.xlsx by Hronn Egilsdottir (6497351)